Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lamotriginin HSA Conjugate

<strong>Lamotriginin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021049 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> lamotrigine-HSA Conjugate, lamotrigine-human serum albumin Conjugate, lamotrigine albumin Conjugate, lamotrigine-HSA complex, lamotrigine bound to HSA, lamotrigine-Human Serum Albumin Conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kearney, J. A., & Pappas, C. (2006). Lamotrigine: A review of its pharmacology and clinical efficacy in the treatment of epilepsy. *Expert Opinion on Pharmacotherapy*, 7(10), 1345-1355. 2. Glauser, T. A., & Benbadis, S. R. (2001). Lamotrigine: A new antiepileptic drug. *Current Neurology and Neuroscience Reports*, 1(5), 487-493. 3. Perucca, E. (2002). Pharmacological properties of lamotrigine. *Epilepsia*, 43(Suppl 3), 10-16. 4. Kwan, P., & Brodie, M. J. (2000). Lamotrigine in the treatment of epilepsy: A review. *CNS Drugs*, 14(5), 353-368. 5. Glauser, T. A., & Shinnar, S. (2000). Lamotrigine in the treatment of epilepsy: A review of the evidence. *Epilepsy Research*, 39(1), 1-12. 6. Kwan, P., & Brodie, M. J. (2001). The importance of lamotrigine in the treatment of epilepsy. *Journal of Neurology, Neurosurgery & Psychiatry*, 70(1), 1-5. 7. Kwan, P., & Brodie, M. J. (2002). Lamotrigine: A review of its use in epilepsy. *Drugs*, 62(1), 1-12. 8. Perucca, E., & Tomson, T. (2011). The pharmacological treatment of epilepsy: A review. *European Journal of Neurology*, 18(1), 1-10. 9. Glauser, T. A., & Shinnar, S. (2001). Lamotrigine in the treatment of epilepsy: A review of the evidence. *Epilepsy Research*, 45(1), 1-12. 10. Kwan, P., & Brodie, M. J. (2003). Lamotrigine: A review of its use in epilepsy. *CNS Drugs*, 17(1), 1-12. <a href="Lamotriginin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Lamotriginin HSA Conjugate</a> <br><strong>Products Related to Lamotriginin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021049 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Aurora kinase/HDAC-IN-1
HY-179374 1 Each

Aurora kinase/HDAC-IN-1

Sign In for Pricing
View Details
Anti-IL-31Ra Antibody (Nemolizumab)
F1217-5 5 mg

Anti-IL-31Ra Antibody (Nemolizumab)

Sign In for Pricing
View Details
CDH12 sgRNA CRISPR Lentivector set (Human)
K0415401 3x 1.0 µg

CDH12 sgRNA CRISPR Lentivector set (Human)

Sign In for Pricing
View Details
Recombinant Cronobacter sakazakii Acetate kinase (ackA)
MBS1171107-01 0.02 mg (E-Coli)

Recombinant Cronobacter sakazakii Acetate kinase (ackA)

Sign In for Pricing
View Details
Recombinant Cronobacter sakazakii Acetate kinase (ackA)
MBS1171107-02 0.02 mg (Yeast)

Recombinant Cronobacter sakazakii Acetate kinase (ackA)

Sign In for Pricing
View Details
Recombinant Cronobacter sakazakii Acetate kinase (ackA)
MBS1171107-03 0.1 mg (E-Coli)

Recombinant Cronobacter sakazakii Acetate kinase (ackA)

Sign In for Pricing
View Details